ARCHIVES

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Study Finds No Evidence That Statins Cut Cancer Risk

January 27, 2006

In Brief: Money Buys Progress In Cancer Research, DeVita says; John Montgomery To Give Clowes Lecture

April 29, 1983

Clinical Education Guidelines Proposed

April 4, 1975

In Brief: Kennedy To Hold Hearing on Mammography Reimbursement, Waxman On Reauthrization

January 15, 1988

FCRF Contracts Hit $40.3 Million With Transfer Of Labs From NIH, Elsewhere

October 8, 1982

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006